NCI increases funding for extramural research by $210M in FY2020; funds more than 125 additional competing awards January 17, 2020Vol.46 No.03By Matthew Bin Han Ong
Conversation with The Cancer LetterFree Robert Winn holds forth on big data, bench-to-community research—and being the only African American director of an NCI-designated cancer center January 17, 2020Vol.46 No.03By Paul Goldberg
Trials & Tribulations Advancing the science of cancer in Latinos January 10, 2020Vol.46 No.02By Amelie G. Ramirez and Ruben A. Mesa
NCI advisors approve seven concepts at joint NCAB/BSA meeting January 10, 2020Vol.46 No.02By Alexandria Carolan
Annals corrects NutriRECS red, processed meat papers to reflect industry-related funding from Texas A&M AgriLife January 10, 2020Vol.46 No.02By Matthew Bin Han Ong
FreeGuest Editorial Immunotherapy, precision medicine in lung cancer drive sharp decline in cancer mortality overall January 08, 2020Vol.46 No.02By Otis W. Brawley
FreeGuest Editorial FDA e-cigarette flavoring ban leaves a bad taste“Trump eroding role of science in government” January 03, 2020Vol.46 No.01By Alan Blum
FDA guidance restricts e-cigarette flavors, leaving tobacco and menthol on the market January 03, 2020Vol.46 No.01By Alexandria Carolan and Matthew Bin Han Ong
Fox Chase acquired by Jefferson in definitive agreement with Temple December 20, 2019Vol.46 No.01By Matthew Bin Han Ong
